Citation Information :
Jyotika. A Review Article on Neurobiological and Psychotherapeutic Approach in Management of Borderline Personality Disorder. 2024; 24 (2):39-44.
McCabe GA, Widiger TA. A comprehensive comparison of the ICD-11 and DSM-5 section III personality disorder models. Psychol Assess 2020;32(1):72–84. DOI: 10.1037/pas0000772
Bozzatello P, Blua C, Marin G, et al. Group interpersonal psychotherapy (IPT-G) for borderline personality disorder: a randomized controlled study. J Psychiatr Res 2023;168:157–164. DOI: 10.1016/j.jpsychires.2023.10.049
ICD-11
DSM-5
Gunderson JG, Zanarini MC, Choi-Kain LW, et al. Family study of borderline personality disorder and its sectors of psychopathology. Arch Gen Psychiatry 2011;68:753–762. DOI: 10.1001/archgenpsychiatry.2011.65
Torgersen S, Lygren S, Oien PA, et al. A twin study of personality disorders. Compr Psychiatry 2000;41:416–425. DOI: 10.1053/comp.2000.16560
Kendler KS, Aggen SH, Czajkowski N, et al. The structure of genetic and environmental risk factors for DSM-IV personality disorders: a multivariate twin study. Arch Gen Psychiatry 2008;65:1438–1446. DOI: 10.1001/archpsyc.65.12.1438
Flasbeck V, Brüne M. Association between childhood maltreatment, psychopathology and DNA methylation of genes involved in stress regulation: evidence from a study in borderline personality disorder. PLoS One. 2021;16(3):e0248514. DOI: 10.1371/journal.pone.0248514
Stanley B, Siever LJ. The interpersonal dimension of borderline personality disorder: toward a neuropeptide model. Am J Psychiatry 2010;167:24–39. DOI: 10.1176/appi.ajp.2009.09050744
Rausch J, Gabel A, Nagy K, et al. Increased testosterone levels and cortisol awakening responses in patients with borderline personality disorder: gender and trait aggressiveness matter. Psychoneuroendocrinology 2015;55:116–127. DOI: 10.1016/j.psyneuen.2015.02.002
Bertsch K, Schmidinger I, Neumann ID, et al. Reduced plasma oxytocin levels in female patients with borderline personality disorder. Horm Behav 2013;63:424–429. DOI: 10.1016/j.yhbeh.2012.11.013
Herpertz SC, Bertsch K. A new perspective on the pathophysiology of borderline personality disorder: a model of the role of oxytocin. Am J Psychiatry 2015;172:840–851. DOI: 10.1176/appi.ajp.2015.15020216
Siever LJ. Neurobiology of aggression and violence. Am J Psychiatry 2008;165:429–442. DOI: 10.1176/appi.ajp.2008.07111774
Barratt ES, Stanford MS, Kent TA, et al. Neuropsychological and cognitive psychophysiological substrates of impulsive aggression. Biol Psychiatry 1997;41:1045–1061. DOI: 10.1016/s0006-3223(96)00175-8
Silbersweig D, Clarkin JF, Goldstein M, et al. Failure of frontolimbic inhibitory function in the context of negative emotion in borderline personality disorder. Am J Psychiatry 2007;164:1832–1841. DOI: 10.1176/appi.ajp.2007.06010126
Dyck M, Loughead J, Kellermann T, et al. Cognitive versus automatic mechanisms of mood induction differentially activate left and right amygdala. Neuroimage 2011;54:2503–2513. DOI: 10.1016/j.neuroimage.2010.10.013
Hansenne M, Pitchot W, Pinto E, et al. 5-HT1A dysfunction in borderline personality disorder. Psychol Med 2002;32:935–941. DOI: 10.1017/s0033291702005445
Soloff P, Nutche J, Goradia D, et al. Structural brain abnormalities in borderline personality disorder: a voxel-based morphometry study. Psychiatry Res 2008;164:223–236. DOI: 10.1016/j.pscychresns.2008.02.003
Schulze L, Schmahl C, Niedtfeld I. Neural correlates of disturbed emotion processing in borderline personality disorder: a multimodal meta-analysis. Biol Psychiatry 2016;79:97–106. DOI: 10.1016/j.biopsych.2015.03.027
Kimmel CL, Alhassoon OM, Wollman SC, et al. Age-related parieto-occipital and other gray matter changes in borderline personality disorder: a meta-analysis of cortical and subcortical structures. Psychiatry Res Neuroimaging 2016;251:15–25. DOI: 10.1016/j.pscychresns.2016.04.005
Koenigsberg HW, Fan J, Ochsner KN, et al. Neural correlates of the use of psychological distancing to regulate responses to negative social cues: a study of patients with borderline personality disorder. Biol Psychiatry 2009;66:854–863. DOI: 10.1016/j.biopsych.2009.06.010
Schmitt R, Winter D, Niedtfeld I, et al. Effects of psychotherapy on neuronal correlates of reappraisal in female patients with borderline personality disorder. Biol Psychiatry Cogn Neurosci Neuroimaging 2016;1:548–557. DOI: 10.1016/j.bpsc.2016.07.003
Perez DL, Vago DR, Pan H, et al. Frontolimbic neural circuit changes in emotional processing and inhibitory control associated with clinical improvement following transference-focused psychotherapy in borderline personality disorder. Psychiatry Clin Neurosci 2016;70(1):51–61. DOI: 10.1111/pcn.12357
Cao Y, Xie H, Sun H, et al. Common and distinct patterns of gray matter alterations in young adults with borderline personality disorder and major depressive disorder. Eur Arch Psychiatry Clin Neurosci 2022;272(8):1569–1582. DOI: 10.1007/s00406-022-01405-9
McMain SF, Chapman AL, Kuo JR, et al. The effectiveness of 6 versus 12 months of dialectical behavior therapy for borderline personality disorder: a noninferiority randomized clinical trial. Psychother Psychosom 2022;91(6):382–397. DOI: 10.1159/000525102
Bedics JD, Atkins DC, Comtois KA, et al. Treatment differences in the therapeutic relationship and introject during a 2-year randomized controlled trial of dialectical behavior therapy versus nonbehavioral psychotherapy experts for borderline personality disorder. J Consult Clin Psychol 2012;80(1):66–77. DOI: 10.1037/a0026113
Neacsiu AD, Lungu A, Harned MS, et al. Impact of dialectical behavior therapy versus community treatment by experts on emotional experience, expression, and acceptance in borderline personality disorder. Behav Res Ther 2014;53:47–54. DOI: 10.1016/j.brat.2013.12.004
Stepp SD, Epler AJ, Jahng S, et al. The effect of dialectical behavior therapy skills use on borderline personality disorder features. J Pers Disord 2008;22(6):549–563. DOI: 10.1521/pedi.2008.22.6.549
Davidson K, Norrie J, Tyrer P, et al. The effectiveness of cognitive behavior therapy for borderline personality disorder: results from the borderline personality disorder study of cognitive therapy (BOSCOT) trial. J Pers Disord 2006;20(5):450–465. DOI: 10.1521/pedi.2006.20.5.450
Juul S, Jakobsen JC, Hestbaek E, et al. Short-term versus long-term mentalization-based therapy for borderline personality disorder: a randomized clinical trial (MBT-RCT). Psychother Psychosom 2023;92(5):329–339. DOI: 10.1159/000534289
Arntz A, Jacob GA, Lee CW, et al. Effectiveness of predominantly group schema therapy and combined individual and group schema therapy for borderline personality disorder: a randomized clinical trial. JAMA Psychiatry 2022;79(4):287–299. DOI: 10.1001/jamapsychiatry.2022.0010
Klein JP, Hauer-von Mauschwitz A, Berger T, et al. Effectiveness and safety of the adjunctive use of an internet-based self-management intervention for borderline personality disorder in addition to care as usual: results from a randomised controlled trial. BMJ Open 2021;11(9):e047771. DOI: 10.1136/bmjopen-2020-047771
Sosic-Vasic Z, Schaitz C, Mayer B, et al. Treating emotion dysregulation in patients with borderline personality disorder using imagery rescripting: a two-session randomized controlled trial. Behav Res Ther 2024;173:104454. DOI: 10.1016/j.brat.2023.104454
Reyes-López J, Ricardo-Garcell J, Armas-Castañeda G, et al. Clinical improvement in patients with borderline personality disorder after treatment with repetitive transcranial magnetic stimulation: preliminary results. Braz J Psychiatry 2018;40(1):97–104. DOI: 10.1590/1516-4446-2016-2112
Schulze L, Grove M, Tamm S, et al. Effects of transcranial direct current stimulation on the cognitive control of negative stimuli in borderline personality disorder. Sci Rep 2019;9(1):332. DOI: 10.1038/s41598-018-37315-x
Zanarini MC, Conkey LC, Temes CM, et al. Randomized controlled trial of web-based psychoeducation for women with borderline personality disorder. J Clin Psychiatry 2018;79(3):16m11153. DOI: 10.4088/JCP.16m11153
Zaehringer J, Ende G, Santangelo P, et al. Improved emotion regulation after neurofeedback: a single-arm trial in patients with borderline personality disorder. Neuroimage Clin 2019;24:102032. DOI: 10.1016/j.nicl.2019.102032